Curis reported $-15940000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Amgen AMGN:US $ 1317M 159M
AstraZeneca AZN:LN 360M 26M
Bayer BAYN:GR € -298M 3589M
Bristol Myers Squibb BMY:US $ 1421M 143M
Chimerix CMRX:US $ -23.47M 1.3M
Curis CRIS:US $ -15.94M 0.17M
Eli Lilly And LLY:US $ 952.5M 950.4M
Epizyme EPZM:US $ -35.74M 19.76M
Exelixis EXEL:US $ 70.67M 2.1M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 838M 964M
Merk MRK:US $ 3944M 366M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Novartis NOVN:VX SF 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Spectrum Pharmaceuticals SPPI:US $ -29.05M 13.61M
Takeda 4502:JP Y 105014M 116372M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
Verastem VSTM:US $ -21.95M 4.99M
Xoma XOMA:US $ -4670000 2.39M
YTE INCY:US $ 161.43M 123.44M